RNAC Competitors & Alternatives
Compare Cartesian Therapeutics Inc. with similar stocks in the same industry
Biotechnology
RNAC
Main Stock$10.04
Tradestie Score
38
Market Cap
$266.26M
Revenue Growth
-0.9%
Analyst Upside
+244.3%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$47.62
|
$353.70M | - | 42 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.11
|
$341.56M | - | 42 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.07
|
$332.96M | - | 42 | Compare |
|
REPL
Replimune Group, Inc.
|
$14.77
|
$328.62M | - | 30 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$17.19
|
$308.74M | - | 48 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$13.13
|
$304.12M | - | 35 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 47 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.63
|
$293.03M | - | 30 | Compare |
|
OMER
Omeros Corporation
|
$19.27
|
$281.75M | 11.2 | 35 | Compare |
More RNAC Analysis
Data updated: Aug 21, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry